Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V T Shetty

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Treatment and Research|November 13, 2001
Cytokines and MDSK Allampallam, V T Shetty, A Raza
Cancer Treatment and Research|November 13, 2001
Novel in vitro culture and ultrastructural techniques to study the biology of myelodysplastic syndromes (MDS)S Alvi, L A Lisak, V T Shetty
Blood|August 21, 2001
Pseudo Pelger-Huët anomaly in myelodysplastic syndrome: hyposegmented apoptotic neutrophil?V T Shetty, S D Mundle, A Raza
Experimental Hematology|October 10, 1998
Is excessive spontaneous intramedullary apoptosis unique to myelodysplasia?S D Mundle, V T Shetty, A Raza
Experimental Hematology|February 24, 2001
Caspases and apoptosis in myelodysplastic syndromesS D Mundle, V T Shetty, A Raza
Ultrastructural Pathology|September 1, 1992
Use of combined myeloperoxidase and immunogold technique in hybrid leukemia: a case reportV T Shetty, S A Kamat, A R Chitale, et al.
American Journal of Hematology|January 12, 1999
Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromesS D Mundle, A Ali, J D Cartlidge, et al.
Blood|October 1, 1996
Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromesS D Mundle, P Venugopal, J D Cartlidge, et al.
Experimental Hematology|June 1, 1997
Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridineA Raza, S Alvi, L Broady-Robinson, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Treatment and Research|November 13, 2001
Cytokines and MDSK Allampallam, V T Shetty, A Raza
Cancer Treatment and Research|November 13, 2001
Novel in vitro culture and ultrastructural techniques to study the biology of myelodysplastic syndromes (MDS)S Alvi, L A Lisak, V T Shetty
Blood|August 21, 2001
Pseudo Pelger-Huët anomaly in myelodysplastic syndrome: hyposegmented apoptotic neutrophil?V T Shetty, S D Mundle, A Raza
Experimental Hematology|October 10, 1998
Is excessive spontaneous intramedullary apoptosis unique to myelodysplasia?S D Mundle, V T Shetty, A Raza
Experimental Hematology|February 24, 2001
Caspases and apoptosis in myelodysplastic syndromesS D Mundle, V T Shetty, A Raza
Ultrastructural Pathology|September 1, 1992
Use of combined myeloperoxidase and immunogold technique in hybrid leukemia: a case reportV T Shetty, S A Kamat, A R Chitale, et al.
American Journal of Hematology|January 12, 1999
Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromesS D Mundle, A Ali, J D Cartlidge, et al.
Blood|October 1, 1996
Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromesS D Mundle, P Venugopal, J D Cartlidge, et al.
Experimental Hematology|June 1, 1997
Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridineA Raza, S Alvi, L Broady-Robinson, et al.
Pageof 1